We are live on ! Find out more
XENE icon

Xenon Pharmaceuticals
XENE

17 hedge funds and large institutions have $83.1M invested in Xenon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+17
Holders Change %
–
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.4M
2
Capital World Investors
Capital World Investors
California
+$9.68M
3
BI
BVF Inc
California
+$9.08M
4
VAM
Visium Asset Management
New York
+$6.61M
5
IPC
Invesco Private Capital
New York
+$6.53M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$24.8M +$18.4M +1,256,239 New
BI
2
BVF Inc
California
$12.2M +$9.08M +618,224 New
Capital World Investors
3
Capital World Investors
California
$11.7M +$9.68M +659,497 New
VAM
4
Visium Asset Management
New York
$8.89M +$6.61M +450,000 New
IPC
5
Invesco Private Capital
New York
$8.78M +$6.53M +444,655 New
EC
6
EcoR1 Capital
California
$6.48M +$4.82M +328,070 New
PA
7
Perceptive Advisors
New York
$4.44M +$3.3M +225,000 New
NHAS
8
Novo Holdings A/S
Denmark
$2.52M +$1.87M +127,563 New
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$1.99M +$1.48M +100,692 New
Caisse de Depot et Placement du Quebec (CDPQ)
10
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$444K +$330K +22,479 New
Goldman Sachs
11
Goldman Sachs
New York
$411K +$305K +20,800 New
Creative Planning
12
Creative Planning
Kansas
$158K +$117K +8,000 New
Wells Fargo
13
Wells Fargo
California
$136K +$101K +6,867 New
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$71K +$52.6K +3,581 New
Bank of America
15
Bank of America
North Carolina
$60K +$44.5K +3,033 New
UBS Group
16
UBS Group
Switzerland
$7K +$5.46K +372 New
Morgan Stanley
17
Morgan Stanley
New York
– +$338 +23 New

XENE Hedge Fund Activity: Q4 2014 in Review

17 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Xenon Pharmaceuticals (XENE) for Q4 2014, worth a combined $83.1M.

Buyers outnumbered sellers: 17 funds opened new XENE positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $18.4M.

  • 17 institutional investors held Xenon Pharmaceuticals (XENE) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $83.1M of Xenon Pharmaceuticals stock for Q4 2014.
  • 17 funds opened new Xenon Pharmaceuticals positions in Q4 2014 and 0 closed out, a net change of +17 holders.
  • The largest Xenon Pharmaceuticals buyer in Q4 2014 was Fidelity Investments, an estimated $18.4M added.

Based on aggregated 13F filings for Q4 2014.